State-by-state data boosts bird conservation planning

New data summaries from the Cornell Lab of Ornithology’s eBird platform will help state wildlife planners assess the status of bird populations that live in or pass through their state – a crucial tool in protecting species.

Professors win Latin@/x Caucus Best Book Award

Shannon Gleeson and Xóchitl Bada are being honored for “Scaling Migrant Worker Rights: How Advocates Collaborate and Contest State Power.“

Around Cornell

New approach moves cell therapy closer to treating many disorders

The study paves the way for using the novel manufacturing process and quality controls to move cell therapy production further along toward applying it in a clinic. 

Going down: Drop in rankings matters more than a rise

People love rankings, but do they really mean that much? Sometimes they do, depending on several factors including the availability of other information, according to new Cornell research.

Childhood HIV vaccination strategy shows promise in study

Research at Weill Cornell Medicine suggests that childhood immunization against HIV could one day provide protection before risk of contracting the potentially fatal infection dramatically increases in adolescence.

Machine learning helps identify rheumatoid arthritis subtypes

The study shows that artificial intelligence and machine learning technologies can effectively and efficiently subtype pathology samples from patients with rheumatoid arthritis.

New school year offers chance to help teens manage stress

The list of stresses teenagers face as they head back to high school is long but there’s plenty that caring parents and guardians, teachers and young people themselves can do to support teens’ mental health, Cornell researchers say.

Eight early-career professors win NSF development awards

Researchers studying artificial intelligence training data and treatment of swelling linked to breast cancer are among the eight Cornell assistant professors who recently received National Science Foundation Faculty Early Career Development Awards.

Rare, deadly liver cancer rewires cell metabolism to grow

Study opens the door to exploring new targets for therapies for fibrolamellar carcinoma, which does not respond to conventional treatments and leaves patients with approximately a year to live on average once it is detected.